Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00719108 · ClinicalTrials.gov registry record · Phase 1
Comparative Glucose Clamp Study of Wockhardt's Insulin Human Regular for Injection and Actrapid, in Healthy Subjects.
A Phase 1 study, sponsored by Wockhardt.
- Completed
- Registry status
- Phase 1
- Development phase
- 42
- Enrollment target
NCT00719108 is a Phase 1 study that has completed, run by Wockhardt. The registered enrollment target is 42 participants.
The verdict
NCT00719108, a Phase 1 study, has completed, sponsored by Wockhardt.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 42 participants
- Enrollment target
Study Summary
The aim of this trial is to demonstrate bioequivalence of Wosulin R to Actrapid with regard to its total and to its maximum serum insulin concentrations.
Interventions
- BIOLOGICAL Wosulin R
- BIOLOGICAL Actrapid
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 42 participants |
| Start Date | 2008-07 |
| Est. Completion | 2008-09 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00719108
The ClinicalTrials.gov registry entry for NCT00719108 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 42 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Wockhardt, which has 27 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Wosulin R is the first listed.
NCT00719108 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00719108 about?
NCT00719108 is a clinical study titled "Comparative Glucose Clamp Study of Wockhardt's Insulin Human Regular for Injection and Actrapid, in Healthy Subjects.". The aim of this trial is to demonstrate bioequivalence of Wosulin R to Actrapid with regard to its total and to its maximum serum insulin concentrations.
What is the current status of trial NCT00719108?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 42 participants. The study started on 2008-07. Estimated completion is 2008-09.
What interventions are being tested in trial NCT00719108?
The interventions under investigation include: Wosulin R (BIOLOGICAL), Actrapid (BIOLOGICAL).
Who is sponsoring clinical trial NCT00719108?
This trial is sponsored by Wockhardt, which has 27 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.